EMCURE PHARMACEUTICALS
Back to Income Statement
|
EMCURE PHARMACEUTICALS Last 5 Year Profit After Tax History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Profit After Tax | ₹707 Cr | ₹528 Cr | ₹562 Cr | ₹703 Cr | ₹419 Cr |
What is the latest Profit After Tax of EMCURE PHARMACEUTICALS ?
| Year | Profit After Tax |
|---|---|
| Mar2025 | ₹707 Cr |
| Mar2024 | ₹528 Cr |
| Mar2023 | ₹562 Cr |
| Mar2022 | ₹703 Cr |
| Mar2021 | ₹419 Cr |
How is Profit After Tax of EMCURE PHARMACEUTICALS Trending?
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2025 | ₹707 Cr | 34.10 | |
| Mar2024 | ₹528 Cr | -6.10 | |
| Mar2023 | ₹562 Cr | -20.03 | |
| Mar2022 | ₹703 Cr | 67.84 | |
| Mar2021 | ₹419 Cr | - | |
Compare Profit After Tax of peers of EMCURE PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| EMCURE PHARMACEUTICALS | ₹27,128.9 Cr | -0.4% | -0.2% | 44% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹423,195.0 Cr | 3% | 9.5% | 3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,849.0 Cr | 1.7% | 3.1% | 5.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,586.0 Cr | 4.7% | 11.7% | 41.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,054.0 Cr | 2.1% | 6.7% | 11.6% | Stock Analytics | |
| CIPLA | ₹108,703.0 Cr | 1.3% | 1.3% | -9.4% | Stock Analytics | |
EMCURE PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| EMCURE PHARMACEUTICALS | -0.4% |
-0.2% |
44% |
| SENSEX | -1.7% |
0.5% |
8.3% |
You may also like the below Video Courses